| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,461 | 1,814 | 2,417 | 1,988 | | Cost of Revenue | 451 | 451 | 495 | 371 | | | Gross Profit | 2,011 | 1,363 | 1,922 | 1,618 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,938 | 2,943 | 2,821 | 3,062 | | Non Recurring | 618 |
-
|
-
|
-
| | Others | 209 | 74 | 73 | 182 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,754) | (1,653) | (972) | (1,627) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (605) | 1,241 | 1,718 | (2,011) | | Earnings Before Interest And Taxes | (2,360) | (412) | 746 | (3,637) | | Interest Expense | 658 | 644 | 649 | 1,307 | | Income Before Tax | (3,018) | (1,056) | 97 | (4,944) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,018) | (1,056) | 97 | (4,944) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,018) | (1,056) | 97 | (4,944) | | Preferred Stock And Other Adjustments | (52) | (52) | (50) | (58) | | | Net Income Applicable To Common Shares | ($3,070) | ($1,108) | $48 | ($5,002) |
|
0.31% Nasdaq 
0.05%
Income Statement
